Ardelyx
ARDX
$6.61
Share price
3.28%
Change (1 day)
42.15%
Change (1 year)
Categories
Ardelyx (ARDX) - Total debt
Total debt on the balance sheet as of December 2023 : $55.98 M
According to Ardelyx's latest financial reports the company's total debt is $55.98 M. A company’s total debt is the sum of all current and non-current debts.
Ardelyx - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $55.98 M | 53.54% |
| 2022-12-31 | $36.46 M | -19.88% |
| 2021-12-31 | $45.5 M | -14.66% |
| 2020-12-31 | $53.31 M | -2.52% |
| 2019-12-31 | $54.69 M | 11.15% |
| 2018-12-31 | $49.2 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $15.62 B | 27,816.12% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 115,317.46% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | 36,281.52% | 🇫🇷 France |
 AstraZeneca AZN | $34.55 B | 61,618.05% | 🇬🇧 UK |
 OPKO Health
OPK | $0.32 B | 483.34% | 🇺🇸 USA |